Well it finally arrived and the market took not one scrap of notice. Nevertheless it is on wards and upwards from here.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago